Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM‐1 and VCAM‐1 expression

L Brucato - British journal of pharmacology, 2008 - Wiley Online Library
Background and purpose: Cyclooxygenase‐2 (COX‐2) is highly expressed during
inflammation and can promote the progression of colorectal cancer. Interactions between …

Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression

C Dianzani, L Brucato, M Gallicchio… - British Journal of …, 2008 - search.proquest.com
Background and purpose: Cyclooxygenase-2 (COX-2) is highly expressed during
inflammation and can promote the progression of colorectal cancer. Interactions between …

Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression

C Dianzani, L Brucato, M Gallicchio… - British journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Background and purpose Cyclooxygenase-2 (COX-2) is highly expressed during
inflammation and can promote the progression of colorectal cancer. Interactions between …

Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.

C Dianzani, L Brucato, M Gallicchio… - British Journal of …, 2008 - search.ebscohost.com
Abstract Background and purpose: Cyclooxygenase-2 (COX-2) is highly expressed during
inflammation and can promote the progression of colorectal cancer. Interactions between …

[引用][C] Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression

C DIANZANI, L BRUCATO… - British journal of …, 2008 - pascal-francis.inist.fr
Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by
inhibiting ICAM-1 and VCAM-1 expression CNRS Inist Pascal-Francis CNRS Pascal and …

[HTML][HTML] Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression

C Dianzani, L Brucato, M Gallicchio… - British Journal of …, 2008 - ncbi.nlm.nih.gov
Background and purpose: Cyclooxygenase-2 (COX-2) is highly expressed during
inflammation and can promote the progression of colorectal cancer. Interactions between …

Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression

C Dianzani, L Brucato, M Gallicchio, AC Rosa… - BRITISH JOURNAL OF …, 2008 - iris.unito.it
Background and purpose: Cyclooxygenase-2 (COX-2) is highly expressed during
inflammation and can promote the progression of colorectal cancer. Interactions between …

[PDF][PDF] Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression

C Dianzani, L Brucato, M Gallicchio… - British Journal of …, 2008 - academia.edu
Background and purpose: Cyclooxygenase-2 (COX-2) is highly expressed during
inflammation and can promote the progression of colorectal cancer. Interactions between …

[引用][C] Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression

C DIANZANI - Br J Pharmacol, 2008 - cir.nii.ac.jp
Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by
inhibiting ICAM-1 and VCAM-1 expression | CiNii Research CiNii 国立情報学研究所 学術情報 …

Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.

C Dianzani, L Brucato, M Gallicchio… - British Journal of …, 2007 - europepmc.org
Background and purpose Cyclooxygenase-2 (COX-2) is highly expressed during
inflammation and can promote the progression of colorectal cancer. Interactions between …